Anthera Pharmaceuticals, Inc.
USD0.00
+0.00 (+0.00%)
CEO
Paul F. Truex
IPO Date
2010-03-01
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.00
Market Cap
$0.00B
Volume
0.02M
| 84,705 |
| $1.65 |
| 9 Jan 2018 | THOMPSON JOHN CRAIG | director, officer: President & CEO | A-Award | Acquired | 1,847,074 | $1.65 |
| 9 Jan 2018 | Thompson David E. | director | A-Award | Acquired | 84,705 | $1.65 |
| 9 Jan 2018 | Sager Philip | director | A-Award | Acquired | 84,705 | $1.65 |
| 9 Jan 2018 | Furse Brent | director | A-Award | Acquired | 84,705 | $1.65 |
| 9 Jan 2018 | SHANAHAN WILLIAM R JR | Chief Medical Officer | A-Award | Acquired | 567,876 | $1.65 |
| 9 Jan 2018 | HENNEY CHRISTOPHER S | director | A-Award | Acquired | 84,705 | $1.65 |
| 20 Sept 2017 | THOMPSON JOHN CRAIG | director, officer: President & CEO | P-Purchase | Acquired | 8,550 | $1.32 |
| 7 Sept 2017 | TRUEX PAUL F | director | P-Purchase | Acquired | 5,000 | $1.34 |